These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38924657)

  • 1. Precision medicine in Asia enhanced by next-generation sequencing: Implications for Thailand through a scoping review and interview study.
    Phanthunane C; Pongcharoen S; Pannarunothai S; Roboon J; Phanthunane P; Nontarak J
    Clin Transl Sci; 2024 Jun; 17(6):e13868. PubMed ID: 38924657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision medicine in Thailand.
    Shotelersuk V; Tongsima S; Pithukpakorn M; Eu-Ahsunthornwattana J; Mahasirimongkol S
    Am J Med Genet C Semin Med Genet; 2019 Jun; 181(2):245-253. PubMed ID: 30888117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current landscape of personalized medicine adoption and implementation in Southeast Asia.
    Chong HY; Allotey PA; Chaiyakunapruk N
    BMC Med Genomics; 2018 Oct; 11(1):94. PubMed ID: 30367635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
    Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging roles of NGS in clinical oncology and personalized medicine.
    Hussen BM; Abdullah ST; Salihi A; Sabir DK; Sidiq KR; Rasul MF; Hidayat HJ; Ghafouri-Fard S; Taheri M; Jamali E
    Pathol Res Pract; 2022 Feb; 230():153760. PubMed ID: 35033746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes and Awareness Toward Pharmacogenomics and Personalized Medicine Adoption Among Health Sciences Trainees: Experience from Greece and Lessons for Europe.
    Siamoglou S; Koromina M; Politopoulou K; Samiou CG; Papadopoulou G; Balasopoulou A; Kanavos A; Mitropoulou C; Patrinos GP; Vasileiou K
    OMICS; 2021 Mar; 25(3):190-199. PubMed ID: 33646050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges Related to the Use of Next-Generation Sequencing for the Optimization of Drug Therapy.
    Zhou Y; Lauschke VM
    Handb Exp Pharmacol; 2023; 280():237-260. PubMed ID: 35792943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings.
    Sukasem C; Jantararoungtong T; Koomdee N
    Drug Metab Pharmacokinet; 2021 Aug; 39():100399. PubMed ID: 34098253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Next Generation Sequencing in Laboratory Medicine.
    Zhong Y; Xu F; Wu J; Schubert J; Li MM
    Ann Lab Med; 2021 Jan; 41(1):25-43. PubMed ID: 32829577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing: implications in personalized medicine and pharmacogenomics.
    Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N
    Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of cancer next-generation sequencing testing in a community hospital.
    Akkari Y; Smith T; Westfall J; Lupo S
    Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards population-specific pharmacogenomics in the era of next-generation sequencing.
    Ji X; Ning B; Liu J; Roberts R; Lesko L; Tong W; Liu Z; Shi T
    Drug Discov Today; 2021 Aug; 26(8):1776-1783. PubMed ID: 33892143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group.
    Yoon S; Kim M; Hong YS; Kim HS; Kim ST; Kim J; Yun H; Yoo C; Ahn HK; Kim HS; Lee IH; Kim IH; Park I; Jeong JH; Cheon J; Kim JW; Yun J; Lim SM; Cha Y; Jang SJ; Zang DY; Kim TW; Kang JH; Kim JH
    Cancer Res Treat; 2022 Jan; 54(1):1-9. PubMed ID: 34902959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The new challenge in oncology: Next-generation sequencing and its application in precision medicine].
    Calabria I; Pedrola L; Berlanga P; Aparisi MJ; Sánchez-Izquierdo D; Cañete A; Cervera J; Millán JM; Castel V
    An Pediatr (Barc); 2016 Nov; 85(5):273.e1-273.e7. PubMed ID: 27349697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation Sequencing Informatics: Challenges and Strategies for Implementation in a Clinical Environment.
    Roy S; LaFramboise WA; Nikiforov YE; Nikiforova MN; Routbort MJ; Pfeifer J; Nagarajan R; Carter AB; Pantanowitz L
    Arch Pathol Lab Med; 2016 Sep; 140(9):958-75. PubMed ID: 26901284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
    Russell LE; Schwarz UI
    Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
    Miller FA; Hayeems RZ; Bytautas JP; Bedard PL; Ernst S; Hirte H; Hotte S; Oza A; Razak A; Welch S; Winquist E; Dancey J; Siu LL
    Eur J Hum Genet; 2014 Mar; 22(3):391-5. PubMed ID: 23860039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.
    Sipeky C; Llerena A; Manolopoulos VG; Pearson E; Mlakar V; Gozzo L; Simmaco M; Marchetti P; Re MD; Stankovic S; Meyer U; Cascorbi I; Ingelman-Sundberg M; Suarez-Kurtz G; Marc J; Katsila T; Paulmichl M; Nofziger C; Ansari M; Drago F; van Schaik RH
    Pharmacogenomics; 2019 Oct; 20(15):1063-1069. PubMed ID: 31588876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and opportunities associated with rare-variant pharmacogenomics.
    Zhou Y; Tremmel R; Schaeffeler E; Schwab M; Lauschke VM
    Trends Pharmacol Sci; 2022 Oct; 43(10):852-865. PubMed ID: 36008164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.